Last edition
News about "Syngene International announces extension of colla"
Syngene International announces extension of collaboration with Amgen Contract extended until 2026
Syngene International yesterday announced the extension of its long-standing multi-discipline research collaboration with Amgen Inc. The contract is currently extended until the end of 2026 and its scope includes integrated drug discovery and development solutions in discovery chemistry and biology, peptide chemistry, antibody and protein reagents
Syngene International Announces Extension Of Colla | 17/12/2021 | By Darshana | 259
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy